News
Orphan drug developers face significant difficulties when navigating market access frameworks in Europe. Could greater use of ...
Ildikó Enyedi, Hungarian director of Oscar-nominated “On Body and Soul” and 2020 Cannes contender “The Story of My Wife,” ...
The European Commission (EC) has granted orphan drug designation to Biodexa Pharmaceuticals’ oral tablet formulation of ...
Naruto Uzumaki, the celebrated ninja, began life as a lonely orphan, shunned by his village due to the Nine-Tailed Fox sealed ...
President Trump recently signed a wide-ranging executive order urging Congress to amend a crucial provision of a Biden-era ...
In this week’s Hearts, Hope & Home, Paige Stockton learns more about how the Panhandle Orphan Care Network supports local ...
Enrollment underway in CHAPTER-3, a pivotal Phase 3 study of deucrictibant for prophylaxis of HAE attacks; topline data expected in 2H2026Attack dataset continues to accumulate in RAPIDe-3, a pivotal ...
6hon MSN
A huge music festival celebrating the very best of local talent will take place this summer at Cleethorpes Cricket Club. On ...
Announced Positive Clinical Data for Adult and Pediatric Netherton Patients ASHBURN, Va., May 13, 2025 (GLOBE NEWSWIRE) -- ...
1h
SuperHeroHype on MSNGodzilla #1 Review: A Superheroic New Take on the King of All MonstersThe first comic born of the Kai-Sei Era of Godzilla introduces a team of superheroes out to save the Earth from Kaiju.
Company advancing plans to develop TPI 287, a novel, late stage abeotaxane that appears to cross the blood-brain barrier and has published clinical efficacy data in glioblastoma multiforme (GBM)Manage ...
Positive phase 3 results from the CAN-2409 clinical trial in intermediate-to-high risk localized prostate cancer have been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results